TREATMENT OF LEUKAEMIAS AND RETICULOSES WITH URACIL MUSTARD

被引:15
作者
WILKINSON, JF
ISRAELS, MCG
BOURNE, MS
机构
来源
BMJ-BRITISH MEDICAL JOURNAL | 1963年 / 534期
关键词
D O I
10.1136/bmj.1.5345.1563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1563 / +
页数:1
相关论文
共 14 条
[1]  
EVANS JS, 1958, P SOC EXP BIOL MED, V99, P620
[2]   URACIL MUSTARD, A NEW ALKYLATING AGENT FOR ORAL ADMINISTRATION IN MANAGEMENT OF PATIENTS WITH LEUKEMIA AND LYMPHOMA [J].
KENNEDY, BJ ;
THEOLOGIDES, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1961, 264 (16) :790-&
[3]  
LANE M, 1960, CANCER RES, V20, P511
[4]  
LANE M, 1960, CANCER CHEMOTH REP, P31
[5]  
LANE M, 1959, CLIN RES, V7, P46
[6]  
LANE MONTAGUE, 1959, PROC AMER ASSOC CANCER RES, V3, P35
[7]  
LEONARD BJ, 1956, LANCET, V271, P1017
[8]   5-BIS-(2-CHLOROETHYL)-AMINOURACIL, A NEW ANTITUMOR AGENT [J].
LYTTLE, DA ;
PETERING, HG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1958, 80 (23) :6459-6460
[9]  
LYTTLE DA, 1959, J NATL CANCER I, V23, P153
[10]  
PORTER FS, 1962, CANCER CHEMOTH REP, P79